4-[4-[4-[4-[4-[[(2S,6R)-4-benzyl-6-hydroxy-2-(hydroxymethyl)-1,4-oxazepan-7-yl]oxy]-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[4-[4-[4-benzyl-6-(hydroxymethyl)morpholin-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-3,5-dihydroxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-(hydroxymethyl)-6-methyloxane-3,5-diol

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 4-[4-[4-[4-[4-[[(2S,6R)-4-benzyl-6-hydroxy-2-(hydroxymethyl)-1,4-oxazepan-7-yl]oxy]-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[4-[4-[4-benzyl-6-(hydroxymethyl)morpholin-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-3,5-dihydroxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-(hydroxymethyl)-6-methyloxane-3,5-diol
• 化学式: C₆₈H₁₀₆N₂O₄₀
• 分子量: 1591.6
• InChiKey: RKWFKGBBGKKMFH-RLJDRBMRSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -9.9
• 重原子数：
  110
• 可旋转键数：
  29
• 环数：
  11.0
• sp3杂化的碳原子比例：
  0.82
• 拓扑面积：
  629
• 氢给体数：
  23
• 氢受体数：
  42

文献信息

• MODIFIED AND DERIVATIZED ß-GLUCAN COMPOUNDS, COMPOSITIONS, AND METHODS
  申请人：Biothera, Inc.

  公开号：US20140228543A1

  公开（公告）日：2014-08-14

  Modified and/or derivativized β-glucans with an enhanced capacity to modulate human immune response as compared to the parent, unmodified and/or underivatized β-glucans are demonstrated.

  改性和/或衍生的β-葡聚糖表现出比未改性和/或未衍生的β-葡聚糖更强的调节人类免疫反应的能力。